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Abstract  
For many years endotracheal intubation and mechanical ventilation have been the standard care for 
very low birth weight infants but, in the last decade, nasal continuous positive airway pressure 
(NCPAP) has been described in many studies as an option for the treatment of preterm infants with 
respiratory distress syndrome. In fact, recent studies have shown that early NCPAP is not associated 
with higher rates of morbidity and mortality and does not imply more days of ventilation support 
when compared to tradition ventilation technics. The authors conducted a study to compare the 
outcomes (in terms of mortality, morbidity and need for medical support) of very low birth weight 
infants treated with NCPAP or endotracheal intubation and mechanical ventilation. One hundred and 
four newborns were enrolled in this study, 44 (42.3%) were treated with NCPAP and 60 (57.7%) 
with endotracheal intubation followed by mechanical ventilation. Afterwards, a subgroup analysis of 
newborns with gestational age between 28 and 31 weeks was performed. It included 57 newborns 
with similar demographic characteristics, 29 (50.9%) treated with NCPAP and 28 (49.1%) with 
endotracheal intubation followed by mechanical ventilation. No statistically significant differences 
were found in the frequency of death or bronchopulmonary dysplasia. Statistically significant 
differences were found in the prevalence of hyaline membrane disease (p=0.033) and surfactant 
administration (p=0.021) with lower rates in the NCPAP group. No other differences were found in 
the prevalence of other morbidities or in the need for medical support after birth. These results 
suggests that NCPAP might be chosen as primary ventilatory support choice in very low birth weight 
preterm, when there are no contraindications to its use. 
 
Keywords: newborn; premature; continuous positive airway pressure; intubation; surfactant;   
hyaline membrane disease 
Introduction  
Approach to the very low birth weight infants (VLBW), in both delivery room and Neonatal 
Intensive Care Unit (NICU), has been changing in the last decade and those changes have led to an 
improvement in the morbidity and mortality rates in most centers [1,2]. 
Assisted ventilation and surfactant have been the standard treatment for VLBW infants [3]. On one 
hand, numerous studies have shown that mechanical ventilation associated with surfactant 
administration lead to a reduction in many complications of premature birth (among others, it leads 
to a decrease in death rates and in the incidence of both bronchopulmonary dysplasia and air leaks) 
[4]. On the other hand, it has been hypothesized that, long term ventilation is associated with lung 
damage and it might be associated with higher rates of bronchopulmonary dysplasia (BDP) [5,6]). 
There are a great number of both observational and clinical trial studies whose data supports that 
early nasal continuous positive airway pressure (NCPAP) is associated with lower rates of 
mechanical ventilation without increase in morbidity and mortality [7-10]. In fact, NCPAP helps the 
achievement of functional residual capacity and the stabilization of the airways and thoracic cage 
[11,12]. 
The aim of our study is to compare the outcomes (morbidity and mortality) of VLBW infants treated 
with NCPAP or endotracheal intubation with mechanical ventilation. 
 
Material and Methods   
The authors performed a retrospective study comparing a strategy of early NCPAP use with 
endotracheal intubation, both started in the delivery room. 
Data from all newborns born in our center, a level III NICU, from 30 June 2007 to 30 June 2012 was 
recorded. The inclusion criteria were birth weight less than 1500g and the need for ventilation at 
birth. Infants with major malformations and those transferred to other units before the completion of 
30 days after birth were excluded from this study.  
The newborns included in the study were stratified into two different subgroups, one treated with 
early NCPAP and another with endotracheal intubation and mechanical ventilation. After global 
analysis, a subgroup analysis was performed and newborns with gestational age between 28 and 31 
weeks were selected since their demographic characteristics were similar. This new group was also 
stratified into two subgroups, one of those treated with early NCPAP and another treated with 
endotracheal intubation and mechanical ventilation. 
The data that was collected from NICU’s data base included information about individual 
characteristics of the mother and prenatal period that are known prenatal risk factors for neonatal 
morbidity (maternal infection, diabetes mellitus, hypertension, eclampsia, pre-eclampsia, gemelar 
pregnancy, delivery method and treatment with steroids during pregnancy), and demographic 
characteristics of the newborn that may be associated with postnatal prognosis (gestational age, birth 
weight, gender and Apgar score) 
Antenatal steroid regimen was performed with betamethasone (divided into two doses of 12 mg 
each) in pregnancies with predictable preterm labor. The decision between early NCPAP and early 
endotracheal intubation was made in the delivery room by the neonatologist. The diagnosis of 
bronchopulmonary dysplasia (BPD) was defined by the need of any supplemental oxygen at 36 
weeks after an attempt at withdrawal of oxygen and the characteristic chest radiograph [5]. 
Exogenous surfactant was administered by Intubation-Surfactant-Extubation (INSURE) or by 
endotracheal intubation followed by mechanical ventilation in the newborns treated with early 
NCPAP and through the endotracheal tube in the newborns treated with early endotracheal 
intubation [9]. Neonatal sepsis was defined by the detection of any microorganism (bacteria or 
fungus) in the blood stream with positive blood culture.   
The primary outcome of this study was the prevalence of death and BPD. Secondary outcomes 
included the major causes of postnatal morbidity (pneumothorax, intraventricular hemorrhage (IVH), 
hyaline membrane disease (HMD), retinopathy of prematurity (ROP), patent ductus arteriosus 
(PDA), sepsis, necrotizing enterocolitis (NEC) and acute renal failure (ARF)) and the need for 
support or medical care after birth (number of days that the newborn requires catheter support, 
ventilation support, oxygen treatment,  number of days with total parenteral nutrition and the number 
of days until full enteral feeding). 
This retrospective study was approved by our institutional ethics committee. Data collection and 
statistical analysis was performed with IBM SPSS Statistics v.20®.  Continuous variables were 
characterized by mean (± standard deviation) and median (medium-maximum) if they had symmetric 
or asymmetric distribution, respectively and categorical variables by absolute and relative 
frequencies. To compare continuous variables we used parametric (independent t test) or non-
parametric (Mann-Whitney U test) tests if they had symmetric or asymmetric distribution, 
respectively and Chi-Squared or Fisher’s exact test to compare categorical variables,  the latest for 
expected values less than 5. A multivariate analysis by logistic regression or multiple linear 
regression (categorical or continuous variables, respectively) was performed. P value less than 0.05 
was considered statistically significant. 
 
Results 
From 2007 to 2012, 156 infants with less than 1500g were born in our center. Fifty-two (33.3%) 
newborns were not eligible for this study (47 were transferred to other NICUs and 5 presented major 
malformations at birth). A total of 104 (66.7%) newborns were enrolled in this study, 44 (42.3%) 
treated with NCPAP and 60 (57.7%) with endotracheal intubation and mechanical ventilation. After 
preliminary evaluation, we found that the two defined groups had too many differences to be 
compared without obvious bias (there were significant statistical differences in gestational age 
(p=<0.0001), birth weight (p=<0.0001), Apgar score at 5th minute (p=<0.0001) and C-section 
delivery (p=0.043)). So, it was decided to select a more balanced group for further analysis and all 
newborns with less than 1500g and between 28 and 31 gestational weeks were selected. A total of 57 
newborn fulfilled the inclusion criteria and 29 (50.9%) infants were treated with NCPAP and 28 
(49.1%) underwent intubation and mechanical ventilation (Figure 1).  
In the group of newborns between 28 and 31 gestational weeks, Apgar score at 5th min was less than 
7 in 16 (57.1%) in endotracheal intubation group and higher than 8 in 26 (89.7%) in NCPAP group 
(p<0.0001). The other demographic and clinical characteristics are summarized in table 1. 
The prevalence of death was 33.3% vs 4.5% (intubation vs NCPAP, p<0.001) in the global analysis 
and 10.7% vs 3.5% (intubation vs NCPAP, p=n.s.) in the group of gestational age 28-31 weeks; the 
prevalence of BPD was 25% vs 13.6% (intubation vs NCPAP, p=n.s.) in the global analysis and 
14.3% vs 13.8% (intubation vs NCPAP, p=n.s.) in the group of gestational age 28-31 wk. The odds 
of death in NCPAP group was OR=2.05 and OR=3.08 (global and subgroup analysis respectively, 
p=n.s.) and the chance of BPD occurrence in NCPAP group was OR=0.77 and OR=0.61 (global and 
subgroup analysis respectively, p=n.s.) when comparing to intubation (table 2). 
There were no significant differences in secondary outcomes in both groups, NCPAP and intubation 
group, excepting the prevalence of HMD which was 51.7%  in the NCPAP group vs 89.3% in 
intubation group (p=0.033) and the need of surfactant which was 55.2% in the NCPAP group vs 
89.3% in intubation group (p=0.021). The secondary outcomes are summarized in table 3. 
In the early NCPAP group we found that one-third (32%) of the newborns needed endotracheal 
intubation at some point of their stay in the NICU. 
 
Discussion  
The prevalence of the primary outcomes (death and BPD) was higher in the intubation group in both 
analysis, but when adjusted for gestational age, birth weight and Apgar score (low birth weight, 
gestational age and Apgar score are widely known to be associated with higher rates of morbidity 
and mortality [13]) we found that there was no statistically significant differences. These results are 
similar to other studies on the role of NCPAP in the prevention of mortality and morbidity in preterm 
infants [14]. Despite this, the chance for death was higher in NCPAP group in both analyses (only 
when adjusted for gestational age, birth weight and Apgar score) and the chance for BPD was higher 
in intubation group in both analysis but not statistically significant in either group. BDP is one of the 
major causes of morbidity and mortality in preterm infants and has been associated with genetic 
background, lung tissue immaturity, mechanical ventilation and oxygen exposure. In fact, despite the 
widening of antenatal steroid and the improvement of ventilation technics the incidence of BPD has 
not decreased [5,15]. Since it is widely accepted that endotracheal intubation is associated with lung 
inflammation and injury [5] these results suggest that a non-invasive approach with early NCPAP 
should be used to avoid mechanical ventilation with endotracheal intubation without the need for 
more days with ventilation treatment.  
Referring to the secondary outcomes our analysis have not found any statistically significant 
differences between the NCPAP and the intubation groups, with the sole exceptions of HMD and 
surfactant treatment. HMD is a major cause of respiratory distress in preterm newborns and the 
standard treatment is the administration of exogenous surfactant [4]. In the study group that only 
included infants from 28 to 31 weeks there was statistical significant differences between the 
prevalence of HMD and surfactant treatment in both groups (NCPAP and intubation). This 
difference might be explained by the nature of this study. Since this was a retrospective study there 
was no intervention of the study coordinators in the choice of ventilation technic. This choice was 
entirely dependent on the neonatologist that assisted the birth and this may result in differences in the 
way similar newborns are treated. This difference can also be explained by differences in preterm 
steroid use. Prenatal steroids are known to reduce the risk of HMD and, although there is no 
statistical significant difference between both groups (when adjusted for birth weight, gestational age 
and Apgar score). Another thing that should be considered in this study is that, since the rate of 
HMD was higher in the mechanical ventilation with endotracheal intubation group, we must consider 
the fact that the newborns in that group might be more prone to higher rates of morbidity than those 
in the NCPAP group. Although this is true, we found no other statistically significant differences 
between the two groups, and that shows that this difference is not a major impairment to the validity 
of the results. 
 
Conclusion 
The results presented by this study supports the use of NCPAP in the early approach of most very 
low birth weight newborns as demonstrated by previous studies. In fact when we adjusted the 
variables for birth weight, gestational age and Apgar score there are no statistical differences in the 
prevalence of death and BPD. There were no other differences in the incidence of other predictable 
outcomes with the exception of HMD and the need for surfactant that was more frequent in the 
intubation group. Previous studies about the role of NCPAP in newborns have also shown this 
decrease in   the incidence of these variables. 
We conclude that NCPAP may be a selected technique in the support of very low birth weight 
newborns with respiratory distress syndrome. 
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Figure 1. Enrollment method   
 
 
GA: gestational age ; NCPAP: nasal continuous positive airway  pressure
Table 1. Demographic and clinical characteristics 
 
 CPAP 
(n=44) 
Intubation 
(n=60) 
 
p 
CPAP  
28-31wk 
(n=29) 
Intubation 
28-31wk 
(n=28) 
 
p 
Gestational age (wk),  mean ± SD 30.3±2 27.1±2 <0.0001
*
 29.4±1 28.9±1 0.108
*
 
Birth weight (g),  
median (min-max) 
1140 
(550-1486) 
860 
(360-1450) 
<0.0001
¥ 1092 
(550-1486) 
1120 
(440-1450) 
`0.943
¥
 
Male Sex, n (%) 14 (33.3) 23 (39) 0.561
§
 9 (33.3) 10 (37) 0.776 
§ 
C-section, n (%) 34 (72.3) 35 (58.3) 0.043
§
 20 (69) 21 (75) 0.612
§
 
Multiple pregnancy, n (%) 13 (29.6) 23 (38.3) 0.352
§
 10 (34.5) 10 (35.7) 0.922 
§
 
Apgar score 5
th
 min, n (%) 
0-7 
8-10 
 
3 (6.8) 
41 (93.2) 
 
38 (63.3) 
22 (36.7) 
 
<0.0001
§
 
 
3 (10.3) 
26 (89.7) 
 
16 (57.1) 
12 (42.9) 
 
<0.0001
§
 
* 
Independent t test, 
¥ 
Mann-Whitney U test, 
§ 
Chi-squared test 
Table 2. Death and BPD adjusted for gestational age and birth weight 
Outcome  All Infants with <1500g 
  All infants with <1500g and 
28-31 gestational weeks 
 
 CPAP 
(n=44) 
Intubation 
(n=60) 
    p OR
*
 P
*
 
CPAP 
(n=29) 
Intubation 
(n=28) 
p OR
*
 p
*
 
Death, n (%) 2 (4.5) 20 (33.3) <0.001
§
  2.05 n.s.   1 (3.5) 3 (10.7) n.s. 3.08 n.s. 
BPD, n (%) 6 (13.6) 15 (25)      n.s.  0.77 n.s.  4 (13.8) 4 (14.3) n.s. 0.61 n.s. 
BPD: Bronchopulmonary dysplasia; 
§ 
Chi-squared test; OR: odds ratio; 
*
Adjusted for gestational age, birth weight and 
Apgar score; n.s.: non-significant 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Prenatal risk factors and major postnatal morbidity causes in newborns with 
28-31 weeks  
 CPAP 
(n=29) 
Intubation 
(n=28) 
P
*
 
Antenatal steroids, n (%) 26 (92.9) 18 (69.2) 0.071 
Maternal infection, n (%) 6 (20.7) 5 (17.9) 0.901 
Maternal diabetes, n (%) 0 1 (3.6) 0.998 
Maternal hypertension, n (%) 1 (3.4) 1 (3.6) 0.369 
Eclampsia, n (%)  0 0 - 
Pre-Eclampsia, n (%) 6 (20.7) 4 (14.3) 0.627 
ROP, n (%) 18 (69.2) 17 (70.8) 0.896 
ARF, n (%) 1 (3.4) 0 0.998 
IVH, n (%) 1 (3.4) 3 (11.5) 0.854 
Sepsis, n (%) 17 (58.6) 13 (46.4) 0.305 
Early onset sepsis, n (%) 2 (6.9) 0 0.998 
HMD, n (%) 15 (51.7) 25 (89.3) 0.033 
Pneumothorax, n (%) 1 (3.4) 1 (3.6) 0.718 
PDA, n (%) 7 (24.1) 8 (32) 0.762 
NEC, n (%) 1 (3.4) 2 (7.1) 0.987 
Surfactant, n (%) 16 (55.2) 25 (89.3) 0.021 
Respiratory support, median days (min-max) 38 (2-70) 35 (1-71) 0.921 
Oxygen therapy, median days (min-max) 2 (0-65) 2 (0-60) 0.380 
TPN, median days (min-max) 21 (6-53) 20 (0-53) 0.963 
Days until full enteral feeding, median (min-max) 23 (8-54) 21 (0-56) 0.914 
Catheterization, median days (min-max) 16 (0-38) 17 (1-50) 0.658 
 ROP: retinopathy of prematurity; ARF: acute renal failure; IVH; intraventricular hemorrhage; HMD: 
hyaline membrane disease; PDA: patent ductus arteriosus; TPN: total parenteral nutrition; NEC: 
necrotizing enterocolitis; 
*
p 
 
adjusted for gestational age, birth weight and Apgar score 
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